New Patient Appointment or 214-645-8300

MedBlog

All cardiac amyloidosis

Heart

New drugs for cardiac amyloidosis provide hope for patients

For decades, there were no FDA-approved treatments for cardiac amyloidosis in the U.S. But in the last two years, two new therapies were approved for cardiac- and nerve-related ATTR. In this week's MedBlog, Justin Grodin, M.D., discusses these therapies and what they mean for North Texas patients.